243 related articles for article (PubMed ID: 10669038)
21. Effect of chronic pentagastrin, cholecystokinin, and secretin on pancreas of rats.
Petersen H; Solomon T; Grossman MI
Am J Physiol; 1978 Mar; 234(3):E286-93. PubMed ID: 343601
[TBL] [Abstract][Full Text] [Related]
22. Guanidinated casein hydrolysate stimulates pancreatic secretagogue release by direct action to the intestine in rats.
Nishi T; Hara H; Kasai T
Proc Soc Exp Biol Med; 1998 Sep; 218(4):357-64. PubMed ID: 9714080
[TBL] [Abstract][Full Text] [Related]
23. The effect of trypsin inhibitor on the pancreas and small intestine of mice.
Ge YC; Morgan RG
Br J Nutr; 1993 Jul; 70(1):333-45. PubMed ID: 8399113
[TBL] [Abstract][Full Text] [Related]
24. Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas.
Douglas BR; Woutersen RA; Jansen JB; de Jong AJ; Rovati LC; Lamers CB
Cancer Res; 1989 May; 49(9):2438-41. PubMed ID: 2706631
[TBL] [Abstract][Full Text] [Related]
25. Adaptation of the human pancreas to inhibition of luminal proteolytic activity.
Friess H; Kleeff J; Isenmann R; Malfertheiner P; Büchler MW
Gastroenterology; 1998 Aug; 115(2):388-96. PubMed ID: 9679044
[TBL] [Abstract][Full Text] [Related]
26. A secretin releasing peptide exists in dog pancreatic juice.
Li P; Song Y; Lee KY; Chang TM; Chey WY
Life Sci; 2000 Feb; 66(14):1307-16. PubMed ID: 10755466
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic, hepatic, and duodenal mucosal bicarbonate secretion during infusion of secretin and cholecystokinin. Evidence of the importance of hepatic bicarbonate in the neutralization of acid in the duodenum of anaesthetized pigs.
Ainsworth MA; Ladegaard L; Svendsen P; Cantor P; Olsen O; Schaffalitzky de Muckadell OB
Scand J Gastroenterol; 1991 Oct; 26(10):1035-41. PubMed ID: 1947769
[TBL] [Abstract][Full Text] [Related]
28. Involvement of gene expressions of cholecystokinin and secretin in luminal feedback regulation in conscious rats.
Miyasaka K; Funakoshi A
Pancreas; 1995 Mar; 10(2):200-3. PubMed ID: 7716145
[TBL] [Abstract][Full Text] [Related]
29. Role of cholecystokinin in cholestyramine-induced changes of the exocrine pancreas.
Koop I; Lindenthal M; Schade M; Trautmann M; Adler G; Arnold R
Pancreas; 1991 Sep; 6(5):564-70. PubMed ID: 1946314
[TBL] [Abstract][Full Text] [Related]
30. Differences in stimulatory effects between rat pancreatic secretory trypsin inhibitor-61 and -56 on rat pancreas.
Miyasaka K; Funakoshi A; Nakamura R; Kitani K; Uda K; Murata A; Ogawa M
Jpn J Physiol; 1989; 39(6):891-9. PubMed ID: 2632901
[TBL] [Abstract][Full Text] [Related]
31. Endogenous CCK release and pancreatic growth in rats after feeding a proteinase inhibitor (camostate).
Göke B; Printz H; Koop I; Rausch U; Richter G; Arnold R; Adler G
Pancreas; 1986; 1(6):509-15. PubMed ID: 3562444
[TBL] [Abstract][Full Text] [Related]
32. Increased CCK-response to proteinase inhibitor feeding after induction of pancreatic hypertrophy in rats.
Göke B; Fenchel K; Knobloch S; Arnold R; Adler G
Pancreas; 1988; 3(5):576-9. PubMed ID: 3186685
[TBL] [Abstract][Full Text] [Related]
33. Regulation of gene expression of pancreatic secretory trypsin inhibitor-61 and -56 by bile and pancreatic juice in rats.
Miyasaka K; Funakoshi A; Nakamura E; Teraoka H
Pancreas; 1995 Oct; 11(3):246-55. PubMed ID: 8577678
[TBL] [Abstract][Full Text] [Related]
34. Different actions of CCK on pancreatic and gastric growth in the rat: effect of CCK(A) receptor blockade.
Varga G; Kisfalvi K; Pelosini I; D'Amato M; Scarpignato C
Br J Pharmacol; 1998 Jun; 124(3):435-40. PubMed ID: 9647465
[TBL] [Abstract][Full Text] [Related]
35. [Effect of intraduodenal oligopeptide on rat pancreatic exocrine secretion and release of secretin and CCK].
Shimizu K
Nihon Shokakibyo Gakkai Zasshi; 1990 Nov; 87(11):2509-16. PubMed ID: 1703583
[TBL] [Abstract][Full Text] [Related]
36. Gastrin and cholecystokinin levels in rats fed soya bean trypsin inhibitor.
Temler RS; Mettraux C
Adv Exp Med Biol; 1986; 199():133-41. PubMed ID: 3799273
[TBL] [Abstract][Full Text] [Related]
37. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice.
Niederau C; Liddle RA; Williams JA; Grendell JH
Gut; 1987; 28 Suppl(Suppl):63-9. PubMed ID: 2446964
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory effect of somatostatin on cholecystokinin release is independent of luminal cholecystokinin-releasing factor content in conscious rats.
Miyasaka K; Masuda M; Kanai S; Ohta M; Suzuki S; Tateishi K; Funakoshi A
Pancreas; 2001 Nov; 23(4):414-20. PubMed ID: 11668212
[TBL] [Abstract][Full Text] [Related]
39. [Study on the trophic effect of camostate mesilate on ethionine-induced pancreatic injury rat].
Oishi T; Nakagawa M; Bamba T; Hosoda S
Nihon Shokakibyo Gakkai Zasshi; 1989 May; 86(5):1125-35. PubMed ID: 2477572
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the effect of lorglumide on pancreatic growth stimulated by camostate in rat and hamster.
Douglas BR; Woutersen RA; Jansen JB; Rovati LC; Lamers CB
Life Sci; 1990; 46(4):281-6. PubMed ID: 2304371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
